clinical trial · NCT05260008
Study Assessing Pain Relief After Replacement of the Knee
Allay Therapeutics, Inc.·phase2·terminated·n = 112
Acute Postoperative PainATX-101ATX-101bupivacaine hydrochloride without epinephrine
brief summary
This is a Phase 2B randomized, double blind, active controlled, multi-center clinical trial to evaluate the safety and efficacy of ATX-101 in participants following total knee arthroplasty. The following is short title and acronym for the study: Study Assessing Pain Relief after Replacement of the Knee (SPARK)
started
Jun 7, 2022
primary completion
Jan 15, 2024
completion
Jan 15, 2024
last updated
Aug 14, 2025
official title
A Phase 2B, Randomized, Double Blind, Active Comparator, Multicenter, Safety, and Efficacy Trial of ATX-101 in Subjects Undergoing Total Knee Arthroplasty
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol